Hsu JT, Liao CK, Le PH, et al. Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer. Medicine (Baltimore). 2015;94(39):e1589. (SCI; IF=1.6; Medicine 118/167 Q3)
CK Liao, CY Yeh, YM Tseng, et al. Neoadjuvant Long Course CCRT Significantly Increases Disease Free Survival among Pathological Stage III Rectal Cancer Patients as Compared to Short Course RT Alone. J Soc Colon Rectal Surgeon (Taiwan). 2017;28(1):18-26.
Liao C-K, Chiang J-M, Tsai W-S, et al. Primary tumor location in stage III colon cancer has prognostic impact on subsequent liver metastasis. J Surg Oncol. 2018;118:1301?1310. (SCI; IF=2.5; Surgery 80/212 Q2)
Liao, CK., Chern, YJ., Lin, YC. et al. Short- and medium-term outcomes of intracorporeal versus extracorporeal anastomosis in laparoscopic right colectomy: a propensity score-matched study. World J Surg Onc 19, 6 (2021). (SCI; IF=3.2; Surgery 44/212 Q1)
Cheng, CC., Hsu, YR., Liao, CK. et al. Minimally invasive right colectomy with transrectal natural orifice extraction: could this be the next step forward?. Tech Coloproctol 24, 1197–1205 (2020).(SCI; IF=3.3; Surgery 43/212 Q1)
Huang SH, Wu RC, Liao CK*, et al. An uncommon form of localized colonic eosinophilic vasculitis with extensive thrombosis of the spleen and liver: A case report and literature review. Int J Surg Case Rep. 2020;75:50-52.
Kuo YT, Chern YJ, Liao CK* et al. Short-course Radiation Therapy Followed by Chemotherapy as Preoperative Treatment for Rectal Cancer. J Soc Colon Rectal Surgeon (Taiwan). 2021;32:7-16
Liao, CK., Yu, YL., Lin, YC. et al. Prognostic value of the C-reactive protein to albumin ratio in colorectal cancer: an updated systematic review and meta-analysis. World J Surg Onc 19, 139 (2021). (SCI; IF=3.2; Surgery 44/212 Q1)
Liao CK, Lin YC, Hsu YJ, Chern YJ, You JF, Chiang JM. Deciding the operation type according to mismatch repair status among hereditary nonpolyposis colorectal cancer patients: should a tailored approach be applied, or does one size fit all? Hered Cancer Clin Pract. 2021 Jun 29;19(1):29. (SCI; IF=1.7; Oncology 221/241 Q4)
Liao C-K, Chern Y-J, Hsu Y-J, Lin Y-C, Yu Y-L, Chiang J-M, Yeh C-Y, You J-F. The Clinical Utility of the Geriatric Nutritional Risk Index in Predicting Postoperative Complications and Long-Term Survival in Elderly Patients with Colorectal Cancer after Curative Surgery. Cancers. 2021; 13(22):5852. (SCI; IF=5.2; Oncology 88/317 Q2)
Jong BK, Cheng CC, Hsu YJ, Chern YJ, Tsai WS, Hung HY, Liao CK, Yeh CY, Hsieh PS, You JF. Transrectal natural orifice specimen extraction in left hemicolectomy for tumours around the splenic flexure: Old wine in new bottles. Colorectal Dis. 2022 Jan;24(1):128-132. (SCI; IF=3.4; Surgery 39/212 Q1)
Kuo YT, Liao CK, Chen TC, Lai CC, Chiang SF, Chiang JM. A high density of PD-L1-expressing immune cells is significantly correlated with favorable disease free survival in nonmetastatic colorectal cancer. Medicine (Baltimore). 2022;101(3):e28573. (SCI; IF=1.6; Medicine 118/167 Q3)
Chern, Y.-J.; You, J.-F.; Cheng, C.-C.; Jhuang, J.-R.; Yeh, C.-Y.; Hsieh, P.-S.; Tsai, W.-S.; Liao, C.-K.; Hsu, Y.-J. Decreasing Postoperative Pulmonary Complication Following Laparoscopic Surgery in Elderly Individuals with Colorectal Cancer: A Competing Risk Analysis in a Propensity Score–Weighted Cohort Study. Cancers 2022, 14, 131. (SCI; IF=5.2; Oncology 88/317 Q2)
Liao, C.-K.; Kuo, Y.-T.; Lin, Y.-C.; Chern, Y.-J.; Hsu, Y.-J.; Yu, Y.-L.; Chiang, J.-M.; Hsieh, P.-S.; Yeh, C.-Y.; You, J.-F. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis. Curr. Oncol. 2022, 29, 3708-3727. (SCI; IF=2.6; Oncology 167/241 Q3)
Liao, C.-K.; Kuo, Y.-T.; Chern, Y.-J.; Hsu, Y.-J.; Lin, Y.-C.; Yu, Y.-L.; Hsieh, P.-S.; Chiang, J.-M.; Yeh, C.-Y.; You, J.-F. Tegafur–Uracil/Leucovorin Plus Oxaliplatin (TEGAFOX) as Consolidation Regimen after Short-Course Radiotherapy Is Effective for Locally Advanced Rectal Cancer. J. Clin. Med. 2022, 11, 2920. (SCI; IF=3.9; Medicine 58/167 Q2)
Lin, Y.-C.; Kuo, Y.-T.; You, J.-F.; Chern, Y.-J.; Hsu, Y.-J.; Yu, Y.-L.; Chiang, J.-M.; Yeh, C.-Y.; Hsieh, P.-S.; Liao, C.-K*. Transanal Total Mesorectal Excision (TaTME) versus Laparoscopic Total Mesorectal Excision for Lower Rectal Cancer: A Propensity Score-Matched Analysis. Cancers 2022, 14, 4098. (SCI; IF=5.2; Oncology 88/317 Q2)
Wang, LM., Jong, BK., Liao, CK. et al. Comparison of short-term and medium-term outcomes between intracorporeal anastomosis and extracorporeal anastomosis for laparoscopic left hemicolectomy. World J Surg Onc 20, 270 (2022). (SCI; IF=3.2; Surgery 44/212 Q1)
Hsu YJ, Chern YJ, Lai IL, Chiang SF, Liao CK, Tsai WS, Hung HY, Hsieh PS, Yeh CY, Chiang JM, Yu YL, You JF. Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy. Open Med (Wars). 2022 Sep 5;17(1):1438-1448 (SCI; IF=2.1; Medicine 109/167 Q3)
You JF, Hsu YJ, Chern YJ, Cheng CC, Jong BK, Liao CK, Hsieh PS, Hsu HC, Tsai WS. Preoperative Cancer Inflammation Prognostic Index as a Superior Predictor of Short- and Long-Term Outcomes in Patients with Stage I-III Colorectal Cancer after Curative Surgery. Cancers (Basel). 2022 Dec 17;14(24):6232. doi: 10.3390/cancers14246232.(SCI; IF=5.2; Oncology 88/317 Q2)
Yu YL, Hsu YJ, Liao CK, Lin YC, You JF, Tsai WS, Jong BK, Chern YJ. Advantage of laparoscopic surgery in patients with generalized obesity operated for colorectal malignancy: A retrospective cohort study. Front Surg. 2023 Jan 6;9:1062746. doi: 10.3389/fsurg.2022.1062746. (SCI; IF=1.8; Surgery 131/213 Q3)
Hsu, CC., Hsu, YJ., Chern, YJ., Liao CK. et al. Potential short-term outcome advantage of low vs. high ligation of inferior mesenteric artery for sigmoid and rectal cancer: propensity score matching analysis. BMC Surg 23, 33 (2023). https://doi.org/10.1186/s12893-023-01932-9 (SCI; IF=1.9; Surgery 120/212 Q3)
Chiang T-Y, Hsu H-C, Chern Y-J, Liao C-K, Hsu Y-J, Tsai W-S, Hsieh P-S, Lin Y-F, Lee H-L, You J-F. Skin Toxicity as a Predictor of Survival in Metastatic Colorectal Cancer Patients Treated with Anti-EGFR: Fact or Fallacy? Cancers. 2023; 15(6):1663. https://doi.org/10.3390/cancers15061663 (SCI; IF=5.2; Oncology 88/317 Q2)
Liao, CK., Kuo, YT., Hsu, YJ. et al. Effect of short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy on organ preservation in locally advanced rectal cancer. Int J Colorectal Dis 38, 92 (2023). https://doi.org/10.1007/s00384-023-04388-8 (SCI; IF=2.8; Surgery 68/212 Q2)
Tsai T-Y, Liao C-K, Zhang B-Y, Huang Y-L, Tsai W-S, You J-F, Yeh C-Y, Hsieh P-S. Perianal Basal Cell Carcinoma—A Systematic Review and Meta-Analysis of Real-World Data. Diagnostics. 2023; 13(9):1650. https://doi.org/10.3390/diagnostics13091650 (SCI; IF=3.6; Medicine 63/167 Q2)
Lo, SJ., Huang, SH., Lai, IL., Liao, CK. et al. Upfront primary tumor resection versus upfront systemic therapy for metastatic colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 38, 186 (2023). https://doi.org/10.1007/s00384-023-04483-w (SCI; IF=2.8; Surgery 68/212 Q2)
Chern YJ, Hsu HY, Hsu YJ, Hsu LY, Tsai WS, Liao CK, Jong BK, You JF. Tumor Marker Trajectories and Survival Analysis in Patients with Normal Carcinoembryonic Antigen Ranges After Colorectal Cancer Resection. Dis Colon Rectum. 2023 Aug 15. doi: 10.1097/DCR.0000000000002894. (SCI; IF=4.1; Surgery 29/213 Q1)
Yu, YL., Tseng, WK., Liao, CK. et al. Using oral tegafur/uracil (UFT) plus leucovorin as adjuvant chemotherapy in stage II colorectal cancer: a propensity score matching study from Taiwan. BMC Cancer 23, 900 (2023). https://doi.org/10.1186/s12885-023-11310-6 (SCI; IF=3.8; Oncology 109/241 Q2)
Hsu Y-J, Chern Y-J, Wu Z-E, Yu Y-L, Liao C-K, Tsai W-S, et al. The oncological outcome and prognostic factors for Solitary Colorectal Liver Metastasis after liver resection. J Gastrointest Surg. 2024. https://doi.org/10.1016/j.gassur.2024.01.003. (SCI; IF=3.2; Surgery 44/213 Q1)
Chiang TY, Hsu YJ, Chern YJ, Liao CK, Tsai WS, Hsieh PS, Hsu HC, Lin YF, Lee HL, You JF. Association between personality types and low anterior resection syndrome in rectal cancer patients following surgery. Cancer Med. 2024 Feb;13(3):e7022. doi: 10.1002/cam4.7022. PMID: 38400678; PMCID: PMC10891461. (SCI; IF=4.0; Oncology 96/241 Q2)